drug · small molecule
patient view →ripasudil hydrochloride
Phase 3updated 2mo agoby Kowa Co Ltd🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for glaucoma and ocular hypertension and 1 investigational indication.
targets
Rho-associated protein kinase
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that